Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Long-Term Debt Issuances (2016 - 2017)

Updated

Avenue Therapeutics (ATXI) reported Long-Term Debt Issuances of $637,000 for FY2017, down 61.9% from $1.67 million in FY2016.

Analysis

Avenue Therapeutics (ATXI) Long-Term Debt Issuances (2016 - 2017) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Issuances came in at $1.67 million in FY2016 (-44.2%) and $3 million in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,129.78 Bn 1,098.36 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 635.44 Bn 555.30 Bn 17.30 Bn -
3 AbbVie 505.13 Bn 478.24 Bn 12.70 Bn -
4 Merck 358.57 Bn 312.95 Bn 12.21 Bn -
5 Novartis Ag 290.63 Bn 254.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 265.17 Bn 238.86 Bn 12.86 Bn -
7 Amgen 237.97 Bn 193.37 Bn 7.24 Bn -
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn -
9 Pfizer 171.50 Bn 118.15 Bn 10.94 Bn -
10 Avenue Therapeutics 1.27 Mn -9.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 567,000.00
Mar 31, 2017 71,000.00
Jun 30, 2016 259,000.00
Mar 31, 2016 875,000.00
API Access

Avenue Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ATXI&period=max&api_key=YOUR_API_KEY